dr. crawford on abiraterone versus enzalutamide in prostate cancer
Published 8 years ago • 699 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
1:34
dr. chi on abiraterone versus enzalutamide for metastatic castration-resistant prostate cancer
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
1:24
dr. crawford discusses prostate cancer biopsies
-
1:42
dr. crawford on prognostic and predictive tests in prostate cancer
-
2:45
dr. crawford on rebiopsying for prostate cancer
-
1:34
e. david crawford on the side effects of treatments for prostate cancer
-
0:41
dr. e. david crawford on sequences and combinations in castration-resistant prostate cancer
-
1:54
dr. crawford discusses improving risk stratification in prostate cancer with the ccp assay
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
1:12
dr. dreicer on the current role of abiraterone and enzalutamide in prostate cancer
-
0:55
dr. crawford on ongoing trials for genetic testing in prostate cancer
-
1:22
dr. bryce on the use of abiraterone versus docetaxel in patients with prostate cancer
-
1:41
dr. oh on abiraterone versus docetaxel in prostate cancer
-
13:04
androgen receptor-targeted ttherapies in advanced prostate cancer
-
0:55
dr. david crawford on sipuleucel-t in advanced prostate cancer
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
1:21
dr. shore on the enzalutamide mechanism of action
-
1:32
dr. hahn discusses abiraterone versus docetaxel in prostate cancer
-
8:12
the use of abiraterone and enzalutamide against crpc